Halozyme Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $29M | 31M | 0.95 |
| 2024-03-31 | $5.9M | 6.6M | 0.88 |
| 2023-09-30 | $4.5M | 5.3M | 0.84 |
| 2023-06-30 | $3.8M | 4.6M | 0.83 |
| 2023-03-31 | $18M | 21M | 0.85 |
| 2022-12-31 | $22M | 23M | 0.97 |
| 2022-06-30 | $20M | 22M | 0.88 |